19 of 102 unique stocks in common · Jaccard: 18.6%
A weighted portfolio overlap of 27.6% indicates a moderate overlap (a meaningful shared core). This means that out of every ₹100 you invest across these two schemes, approximately ₹27.6 is allocated to the exact same companies at the same relative proportions. The schemes share 19 common holdings.
The largest overlapping asset in their portfolios is HDFC Bank, which commands a weight of 7.33% in DSP Quant Fund and 8.46% in ICICI Prudential Large Cap Fund. Holding both schemes increases your concentration in HDFC Bank rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in DSP | in ICICI |
|---|---|---|
| HDFC BankBanks | 7.33% | 8.46% |
| Bharti AirtelTelecom - Services | 3.37% | 4.34% |
| Larsen & ToubroConstruction | 3.00% | 5.38% |
| InfosysIT - Software | 2.94% | 3.60% |
| Maruti Suzuki IndiaAutomobiles | 1.72% | 3.55% |
| Hero MotoCorpAutomobiles | 2.33% | 1.59% |
| Hyundai Motor IndiaAutomobiles | 1.84% | 0.95% |
| ITCDiversified FMCG | 2.27% | 0.94% |
| Britannia IndustriesFood Products | 2.36% | 0.91% |
| Cummins IndiaIndustrial Products | 2.83% | 0.91% |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | 1.67% | 0.87% |
| HDFC Asset Management CompanyCapital Markets | 2.15% | 0.69% |
| Eicher MotorsAutomobiles | 2.67% | 0.62% |
| HCL TechnologiesIT - Software | 2.63% | 0.47% |
| Zydus LifesciencesPharmaceuticals & Biotechnology | 2.52% | 0.40% |
| ABB IndiaElectrical Equipment | 1.86% | 0.36% |
| LupinPharmaceuticals & Biotechnology | 2.18% | 0.19% |
| WiproIT - Software | 2.10% | 0.17% |
| Bajaj AutoAutomobiles | 2.75% | 0.17% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.